Overview

Maintaining Nonsmoking

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The research is based on a chronic disorder model of cigarette smoking which suggests that long-term treatment targeted to prevent relapse may be useful. Based on this model, the investigators have developed a relapse prevention treatment to intervene on five areas important in relapse prevention, including fluctuating motivation, depression, withdrawal, weight gain, and social support. This treatment protocol has produced high long-term abstinence rates when implemented in a clinical research setting. The current study will evaluate the treatment model when implemented in a medical outpatient setting.
Phase:
Phase 3
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
National Institute on Drug Abuse (NIDA)
Pfizer
Treatments:
Varenicline